[1]
Özge Kaya, Z. Keskinkaya, S. Işık Mermutlu, S. Oğuz Kılıç, and S. Öztürk, “Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?”, Dermatol Pract Concept, vol. 13, no. 3, p. e2023145, Jul. 2023, doi: 10.5826/dpc.1303a145.